Gait and Alzheimer Interaction Tracking (GAIT) Study — GAIT  

Alzheimer Disease Clinical Trial

Official title: Maladie d'Alzheimer et Troubles Locomoteurs : Caracterisation Des Anomalies Temporelles de la Marche et Etude Des Correlats Anatomo-cognitifs

Status Completed

Clinical Trial Summary

The purpose of this study is to examine and to compare gait characteristics under single- and dual-task conditions among healthy subjects together with AD patients at different stages of disease (i.e., pre-dementia, mild and moderate dementia stages).

Clinical Trial Description

Although gait disorders are frequently associated with Alzheimer's disease (AD), few studies have focused on their characterization and mechanism. Exploring the associations of the gait characteristics - more particularly the gait variability - with the cognitive performance of AD patients on one hand, and with the morphological brain abnormalities on the other hand, could be useful to understanding the mechanisms of gait disorders in AD.

The main objective of this study is to examine and to compare gait characteristics under single- and dual-task conditions among healthy subjects together with AD patients at different stages of disease (i.e., pre-dementia, mild and moderate dementia stages). ;

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Alzheimer Disease
• Apraxias
• Atrophy
• Cerebral Atrophy
• Gait Apraxia
• Impaired Cognition

• NCT number: NCT01315717
• Study type: Observational
• Source: University Hospital, Angers
• Status: Completed
• Phase: N/A
• Start date: November 2009
• Completion date: May 2016